metyrapone has been researched along with Acute Myelogenous Leukemia in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Resnitzky, P | 1 |
| Estrov, Z | 1 |
| Haran-Ghera, N | 1 |
| Boga, M | 1 |
| Halmy, L | 1 |
| Rutkai, P | 1 |
2 other studies available for metyrapone and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
High incidence of acute myeloid leukemia in SJL/J mice after X-irradiation and corticosteroids.
Topics: Adrenal Cortex Hormones; Animals; Female; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Met | 1985 |
Diabetes insipidus occurring with acute leukaemia.
Topics: Adrenal Glands; Adult; Cicatrix; Diabetes Insipidus; Hemorrhage; Humans; Leukemia, Myeloid, Acute; L | 1970 |